Higher levels of salivary alpha-amylase predict failure of cessation efforts in male smokers.
The ability to predict the success or failure of smoking cessation efforts will be useful for clinical practice. Stress response is regulated by two primary neuroendocrine systems. Salivary cortisol has been used as a marker for the hypothalamus-pituitary-adrenocortical axis and salivary alpha-amylase as a marker for the sympathetic adrenomedullary system. We studied 62 chronic smokers (34 women and 28 men with an average age of 45.2+/-12.9 years). The levels of salivary cortisol and salivary alpha-amylase were measured during the period of active smoking, and 6 weeks and 24 weeks after quitting. We analyzed the men separately from the women. The men who were unsuccessful in cessation showed significantly higher levels of salivary alpha-amylase over the entire course of the cessation attempt. Before stopping smoking, salivary cortisol levels were higher among the men who were unsuccessful in smoking cessation. After quitting, there were no differences between this group and the men who were successful in cessation. In women we found no differences between groups of successful and unsuccessful ex-smokers during cessation. In conclusions, increased levels of salivary alpha-amylase before and during smoking cessation may predict failure to quit in men. On the other hand, no advantage was found in predicting the failure to quit in women. The results of our study support previously described gender differences in smoking cessation.
Dušková
M
M
Institute of Endocrinology, Prague, Czech Republic. mduskova@endo.cz
Šimůnková
K
K
Hill
M
M
Hruškovičová
H
H
Hoskovcová
P
P
Králíková
E
E
Stárka
L
L
D000328:Adult; D015415:Biomarkers / Q000378:metabolism*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012463:Saliva / Q000201:enzymology*; D012727:Sex Characteristics; D012907:Smoking / Q000378:metabolism; D016540:Smoking Cessation; D013564:Sympathetic Nervous System / Q000378:metabolism; D017211:Treatment Failure; D000516:alpha-Amylases / Q000378:metabolism*
D015415:Biomarkers; D000516:alpha-Amylases; D006854:Hydrocortisone